Michael Offin
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Cancer-related gene regulation, Occupational and environmental lung diseases
Most-Cited Works
- → Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial(2018)551 cited
- → High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden(2019)489 cited
- → Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes(2019)437 cited
- → Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer(2021)408 cited
- → Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR -Mutant Lung Cancer(2020)373 cited
- → Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR -Mutant Lung Cancers(2018)329 cited
- → PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers(2018)317 cited
- → HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers(2020)278 cited
- → COVID-19 in patients with lung cancer(2020)269 cited
- → Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers(2018)227 cited